PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.10%
Revenue growth under 50% of FSLR's 47.86%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
15.31%
Gross profit growth under 50% of FSLR's 177.03%. Michael Burry would be concerned about a severe competitive disadvantage.
44.28%
EBIT growth below 50% of FSLR's 297.58%. Michael Burry would suspect deeper competitive or cost structure issues.
23.57%
Operating income growth under 50% of FSLR's 297.58%. Michael Burry would be concerned about deeper cost or sales issues.
42.88%
Net income growth under 50% of FSLR's 300.79%. Michael Burry would suspect the firm is falling well behind a key competitor.
34.48%
EPS growth under 50% of FSLR's 300.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
34.48%
Diluted EPS growth under 50% of FSLR's 297.50%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.29%
Share count expansion well above FSLR's 0.14%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.29%
Diluted share count expanding well above FSLR's 0.12%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
87.22%
Positive OCF growth while FSLR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
77.66%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
-44.47%
Negative 10Y revenue/share CAGR while FSLR stands at 30.24%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-16.93%
Negative 5Y CAGR while FSLR stands at 157.05%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
27.52%
3Y revenue/share CAGR similar to FSLR's 25.13%. Walter Schloss would assume both companies experience comparable short-term cycles.
81.97%
Positive long-term OCF/share growth while FSLR is negative. John Neff would see a structural advantage in sustained cash generation.
88.61%
Positive OCF/share growth while FSLR is negative. John Neff might see a comparative advantage in operational cash viability.
-181.21%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-210.21%
Negative 10Y net income/share CAGR while FSLR is at 323.94%. Joel Greenblatt sees a major red flag in long-term profit erosion.
94.38%
Below 50% of FSLR's 445.02%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-256.41%
Negative 3Y CAGR while FSLR is 358.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-65.63%
Negative equity/share CAGR over 10 years while FSLR stands at 21.32%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
1001.41%
5Y equity/share CAGR above 1.5x FSLR's 15.90%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1362.76%
3Y equity/share CAGR above 1.5x FSLR's 14.58%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.28%
AR growth is negative/stable vs. FSLR's 105.98%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
11.05%
Inventory growth well above FSLR's 0.63%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.45%
Similar asset growth to FSLR's 5.05%. Walter Schloss finds parallel expansions or investment rates.
-5.37%
We have a declining book value while FSLR shows 2.77%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.31%
Debt growth far above FSLR's 36.53%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-10.20%
Our R&D shrinks while FSLR invests at 20.44%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-8.99%
We cut SG&A while FSLR invests at 5.22%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.